Your browser doesn't support javascript.
loading
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
Ducassou, Stéphane; Fernandes, Helder; Savel, Hélène; Bertrand, Yves; Leblanc, Thierry; Abou Chahla, Wadih; Pasquet, Marlène; Leverger, Guy; Barlogis, Vincent; Thomas, Caroline; Bayart, Sophie; Pellier, Isabelle; Armari-Alla, Corinne; Guitton, Corinne; Cheikh, Nathalie; Kherfellah, Djamel; Vassal, Gilles; Thiébaut, Rodolphe; Laghouati, Salim; Aladjidi, Nathalie.
Affiliation
  • Ducassou S; Pediatric Hematology Unit, CIC1401, INSERM CICP, University Hospital of Bordeaux, Bordeaux, France; Centre de Référence National des Cytopénies Autoimmunes de l'Enfant (CEREVANCE), University Hospital of Bordeaux, Bordeaux, France.
  • Fernandes H; Centre de Référence National des Cytopénies Autoimmunes de l'Enfant (CEREVANCE), University Hospital of Bordeaux, Bordeaux, France.
  • Savel H; Unité de Soutien Méthodologique à la Recherche Clinique (USMR) University Hospital of Bordeaux, Bordeaux, France.
  • Bertrand Y; Pediatric Hematology Unit, Institute of Pediatric Hematology and Oncology, Claude Bernard University Lyon, Lyon, France.
  • Leblanc T; Department of Hematology, APHP - Hopital Robert Debré, Centre de Ré́férence National des Cytopénies Autoimmunes de l'Enfant (CEREVANCE), Paris, France.
  • Abou Chahla W; Department of pediatric Hematology, University Hospital of Lille, Lille, France.
  • Pasquet M; Department of pediatric Hematology, University Hospital of Toulouse, Toulouse, France.
  • Leverger G; Sorbonne Université, INSERM, Centre de Recherche Saint Antoine, AP-HP, Hôpital Armand Trousseau, Service d'Hématologie Oncologie Pédiatrique, Centre de Référence National des Cytopénies Autoimmunes de lEnfant (CEREVANCE), Paris, France.
  • Barlogis V; Department of Pediatric Hematology AP-HM Hôpital Timone Enfant, Marseille, France.
  • Thomas C; Department of Pediatric Hematology and Oncology, University Hospital of Nantes, Nantes, France.
  • Bayart S; Department of Pediatric Hematology, University Hospital of Rennes, Rennes, France.
  • Pellier I; Department of Pediatric Hematology and Oncology, University Hospital of Angers, Angers, France.
  • Armari-Alla C; Department of Pediatric Hematology, University Hospital of Grenoble, Grenoble, France.
  • Guitton C; Department of Pediatrics, University Hospital of Bicêtre, Le Kremlin-Bicêtre, France.
  • Cheikh N; Department of Pediatric Hematology and Oncology, University Hospital of Besançon, Besançon, France.
  • Kherfellah D; Centre de Référence National des Cytopénies Autoimmunes de l'Enfant (CEREVANCE), University Hospital of Bordeaux, Bordeaux, France.
  • Vassal G; Gustave Roussy Cancer Center, Clinical Research Direction, Paris-Saclay University, Villejuif, France.
  • Thiébaut R; Unité de Soutien Méthodologique à la Recherche Clinique (USMR) University Hospital of Bordeaux, Bordeaux, France.
  • Laghouati S; Gustave Roussy Cancer Center, Pharmacovigilance Unit, Paris-Saclay University, Villejuif, France.
  • Aladjidi N; Pediatric Hematology Unit, CIC1401, INSERM CICP, University Hospital of Bordeaux, Bordeaux, France; Centre de Référence National des Cytopénies Autoimmunes de l'Enfant (CEREVANCE), University Hospital of Bordeaux, Bordeaux, France. Electronic address: nathalie.aladjidi@chu-bordeaux.fr.
J Pediatr ; 231: 223-230, 2021 04.
Article in En | MEDLINE | ID: mdl-33340549

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenectomy / Azathioprine / Purpura, Thrombocytopenic, Idiopathic / Immunomodulation / Rituximab / Hydroxychloroquine Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Pediatr Year: 2021 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenectomy / Azathioprine / Purpura, Thrombocytopenic, Idiopathic / Immunomodulation / Rituximab / Hydroxychloroquine Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Pediatr Year: 2021 Document type: Article Affiliation country: Francia